GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » EV-to-Revenue

Schott Pharma AG KGaA (XTER:1SXP) EV-to-Revenue : 5.18 (As of May. 28, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Schott Pharma AG KGaA's enterprise value is €4,658.3 Mil. Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €898.6 Mil. Therefore, Schott Pharma AG KGaA's EV-to-Revenue for today is 5.18.

The historical rank and industry rank for Schott Pharma AG KGaA's EV-to-Revenue or its related term are showing as below:

XTER:1SXP' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.73   Med: 5.69   Max: 6.83
Current: 5.18

During the past 4 years, the highest EV-to-Revenue of Schott Pharma AG KGaA was 6.83. The lowest was 4.73. And the median was 5.69.

XTER:1SXP's EV-to-Revenue is ranked worse than
66.67% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.25 vs XTER:1SXP: 5.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Schott Pharma AG KGaA's stock price is €30.62. Schott Pharma AG KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was €5.97. Therefore, Schott Pharma AG KGaA's PS Ratio for today is 5.13.


Schott Pharma AG KGaA EV-to-Revenue Historical Data

The historical data trend for Schott Pharma AG KGaA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA EV-to-Revenue Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23
EV-to-Revenue
- - - 5.36

Schott Pharma AG KGaA Semi-Annual Data
Sep20 Sep21 Sep22 Sep23
EV-to-Revenue - - - 5.36

Competitive Comparison of Schott Pharma AG KGaA's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's EV-to-Revenue falls into.



Schott Pharma AG KGaA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Schott Pharma AG KGaA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4658.273/898.602
=5.18

Schott Pharma AG KGaA's current Enterprise Value is €4,658.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was €898.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA  (XTER:1SXP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Schott Pharma AG KGaA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=30.62/5.966
=5.13

Schott Pharma AG KGaA's share price for today is €30.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was €5.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA (XTER:1SXP) Business Description

Traded in Other Exchanges
Address
Hattenbergstraße 10, Mainz, DEU, 55122
Schott Pharma AG & CO KGaA is a multinational glass company specializing in the manufacture of glass and glass ceramics. It is represented in 34 countries and serves a multitude of industries from Healthcare, Home Appliances and living, and Consumer Electronics to Semiconductors and datacom, Optics, Industry and energy, Automotive, and Astronomy and aerospace.
Executives
Andreas Reisse Board of Directors
Ann-kristin Erkens Supervisory Board
Dr. Almuth Steinkühler Board of Directors
Dr. Jens Schulte Supervisory Board
Dr. Wolfgang Wienand Supervisory Board
Peter Goldschmidt Supervisory Board

Schott Pharma AG KGaA (XTER:1SXP) Headlines

No Headlines